Delivery Order SPE2DB24D2217-SPE2DB25FJXTR
Award Date 9/15/25
Potential Completion Date 10/6/25
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,676.12 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of INGREZZA 40 mg capsules (30-count units). This is a firm fixed-price contract with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. INGREZZA is a pharmaceutical treatment used in military and...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of INGREZZA 80 mg capsules (30-count units) under a firm fixed-price arrangement valued at $4,027.70. This non-competitive delivery order is scheduled for completion by September 2, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INGREZZA 80 MG capsules (30-count supply) valued at $4,027.70 under a firm fixed price contract. The award was made on September 11, 2025, with an ultimate completion date of October 2, 2025. This is a non-set-aside competitive award executed as a delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of...
- The Defense Logistics Agency awarded a delivery order valued at $4,049.61 to AmerisourceBergen Drug Corp for INGREZZA 60 mg capsules (30-count packaging) on September 10, 2025, with an ultimate completion date of October 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of involuntary movement...
- The Defense Logistics Agency awarded a $4,027.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count packaging) on September 16, 2025, with a completion date of October 7, 2025. This non-set-aside award was competitively procured and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat involuntary movement disorders, representing a specialized...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of INGREZZA 60 mg capsules (30-count units) valued at $4,049.61. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract completion date is set for June 24, 2025, and performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. INGREZZA is a prescription medication...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units) on June 2, 2025, with an ultimate completion date of June 24, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a pharmaceutical treatment indicated for tardive dyskinesia, a neurological movement disorder,...
- The Defense Logistics Agency awarded a $11,028.36 delivery order to AmerisourceBergen Drug Corp for INGREZZA 40 MG capsules (30-count units) on August 25, 2025, with completion expected by September 16, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units) with a ceiling value of $4,027.70. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with performance to be completed by August 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will execute this order from its corporate office location. This delivery order is issued under...